Beth Eastland

Beth Eastland joined NeoGenomics in December of 2024 as the Senior Vice President of Enterprise Sales. Most recently, she served as General Manager for the commercial screening team at Exact Sciences and prior to that, served as the Vice President of Health Systems and Specialty, playing a key role in the development of the health system strategy at Exact Sciences including the development of health systems account manager and health technology teams, executing highly successful growth strategies to accelerate growth in key oncology and screening diagnostics. Her prior 30 years of experience in pharmaceuticals included responsibilities with broad leadership and strategic roles including sales, marketing, market access, strategy and operations in both the US and global markets at Merck from 1989-2015. She gained additional experience in senior leadership roles in mid-size and start-up companies with key launch brands before her transition to diagnostics in 2018. Beth brings significant experience in operating model transformation, commercial execution, strategic customer collaborations, and maximizing growth opportunities. She earned an undergraduate degree in Chemistry from Duke University and completed a certificate program in Science, Technology and Human Values.